Lower leukotriene C4 levels in asthmatic subjects after inhaled corticosteroid therapy
Author Information
Author(s): Y. Oosterhoff, S. E. Overbeek, R. Douma, J. A. Noordhoek, D. S. Postma, H. C. Hoogsteden, F. J. Zijlstra
Primary Institution: University Hospital Groningen, Dijkzigt University Hospital Rotterdam, Erasmus University Rotterdam
Hypothesis
Does long-term treatment with inhaled corticosteroids affect arachidonic acid metabolite levels in asthmatic patients?
Conclusion
Inhaled corticosteroids significantly lower leukotriene C4 levels in asthmatic patients after 2.5 years of treatment.
Supporting Evidence
- Patients treated with inhaled corticosteroids showed significantly lower levels of leukotriene C4 in bronchoalveolar lavage fluid.
- Long-term corticosteroid treatment was associated with improved lung function in asthmatic patients.
- Significant correlations were found between lower leukotriene levels and better lung function parameters.
Takeaway
Asthma patients who used inhaled corticosteroids for a long time had lower levels of a substance that can make their breathing worse.
Methodology
The study involved a randomized, double-blind trial comparing bronchoalveolar lavage fluid from asthmatic patients treated with inhaled corticosteroids versus those treated with bronchodilators alone.
Limitations
The study may have limitations due to the small sample size and the specific patient selection criteria.
Participant Demographics
22 non-smoking asthmatic subjects, with a mix of genders and ages ranging from 23 to 60 years.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website